Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events

NCT01179048 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01179048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01179048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2010
Completion date
December 17, 2015
Enrollment
9,341 (actual)
Sites
428

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2